188 related articles for article (PubMed ID: 35363917)
1. Diagnosis and treatment of Helicobacter pylori infection by physicians in China: A nationwide cross-sectional study.
Song Z; Chen Y; Lu H; Zeng Z; Wang W; Liu X; Zhang G; Du Q; Xia X; Li C; Jiang S; Wu T; Li P; He S; Zhu Y; Zhang G; Xu J; Li Y; Huo L; Lan C; Miao Y; Jiang H; Chen P; Shi L; Tuo B; Zhang D; Jiang K; Wang J; Yao P; Huang X; Yang S; Wang X; Zhou L
Helicobacter; 2022 Jun; 27(3):e12889. PubMed ID: 35363917
[TBL] [Abstract][Full Text] [Related]
2. Management of Helicobacter pylori infection by clinicians: A nationwide survey in a developing country.
Song C; Xie C; Zhu Y; Liu W; Zhang G; He S; Zheng P; Lan C; Zhang Z; Hu R; Du Q; Xu J; Chen Y; Zeng Z; Cheng H; Wang X; Zuo X; Lu H; Guo T; Chen Z; Xie Y; Lu N
Helicobacter; 2019 Dec; 24(6):e12656. PubMed ID: 31571330
[TBL] [Abstract][Full Text] [Related]
3. Adherence to Maastricht V/Florence consensus report for the management of Helicobacter pylori infection among primary care physicians and medical students in Croatia: A cross-sectional study.
Jukic I; Vukovic J; Rusic D; Bozic J; Bukic J; Leskur D; Seselja Perisin A; Modun D
Helicobacter; 2021 Apr; 26(2):e12775. PubMed ID: 33368852
[TBL] [Abstract][Full Text] [Related]
4. Attitudes and practice related to Helicobacter pylori infection among primary care physicians.
Boltin D; Kimchi N; Dickman R; Gingold-Belfer R; Niv Y; Birkenfeld S
Eur J Gastroenterol Hepatol; 2016 Sep; 28(9):1035-40. PubMed ID: 27167452
[TBL] [Abstract][Full Text] [Related]
5. Optimum duration of regimens for Helicobacter pylori eradication.
Yuan Y; Ford AC; Khan KJ; Gisbert JP; Forman D; Leontiadis GI; Tse F; Calvet X; Fallone C; Fischbach L; Oderda G; Bazzoli F; Moayyedi P
Cochrane Database Syst Rev; 2013 Dec; (12):CD008337. PubMed ID: 24338763
[TBL] [Abstract][Full Text] [Related]
6. The Diagnosis and Therapy of Helicobacter pylori Infection in Hungary: Comparison of Strategies Applied by Family Physicians and Internists.
Márkus B; Herszényi L; Matyasovszky M; Vörös K; Torzsa P; Rurik I; Tulassay Z; Kalabay L
Dig Dis; 2019; 37(6):434-443. PubMed ID: 31067529
[TBL] [Abstract][Full Text] [Related]
7. Clinical practice of Helicobacter pylori infection management by gastroenterologists in secondary and tertiary hospitals: A stratified sampling cross-sectional survey.
Zhang WL; Li YY; Liu J; Wang J; Wan M; Lin BS; Lin MJ; Ding YM; Kong QZ; Wang ST; Duan M; Han ZX; Ji R; Zuo XL; Li YQ
J Dig Dis; 2022 Jul; 23(7):365-375. PubMed ID: 35880374
[TBL] [Abstract][Full Text] [Related]
8. Comparison of four different regimens against Helicobacter pylori as a first-line treatment: A prospective, cross-sectional, comparative, open trial in Chinese children.
Zhou Y; Ye Z; Wang Y; Zhang Y; Tang Z; Yan W; Jiang Y; Huang Y
Helicobacter; 2020 Apr; 25(2):e12679. PubMed ID: 31958193
[TBL] [Abstract][Full Text] [Related]
9. Awareness and attitudes regarding Helicobacter pylori infection in Chinese physicians and public population: A national cross-sectional survey.
Wu Y; Su T; Zhou X; Lu N; Li Z; Du Y
Helicobacter; 2020 Aug; 25(4):e12705. PubMed ID: 32476197
[TBL] [Abstract][Full Text] [Related]
10. Second-line rescue treatment of
Lin TF; Hsu PI
World J Gastroenterol; 2018 Oct; 24(40):4548-4553. PubMed ID: 30386104
[TBL] [Abstract][Full Text] [Related]
11. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report.
Malfertheiner P; Megraud F; O'Morain C; Bazzoli F; El-Omar E; Graham D; Hunt R; Rokkas T; Vakil N; Kuipers EJ
Gut; 2007 Jun; 56(6):772-81. PubMed ID: 17170018
[TBL] [Abstract][Full Text] [Related]
12. Application of Maastricht 2-2000 guidelines for the management of Helicobacter pylori among specialists and primary care physicians in israel: are we missing the malignant potential of Helicobacter pylori?
Shirin H; Birkenfeld S; Shevah O; Levine A; Epstein J; Boaz M; Niv Y; Avni Y
J Clin Gastroenterol; 2004 Apr; 38(4):322-5. PubMed ID: 15087690
[TBL] [Abstract][Full Text] [Related]
13. Review: clinical management of Helicobacter pylori infection in China.
Xie C; Lu NH
Helicobacter; 2015 Feb; 20(1):1-10. PubMed ID: 25382801
[TBL] [Abstract][Full Text] [Related]
14. Eradication rate of Helicobacter pylori reinfection in Korea: A retrospective study.
Choi YK; Ahn JY; Won SH; Jung K; Na HK; Jung KW; Kim DH; Lee JH; Choi KD; Song HJ; Lee GH; Jung HY
J Gastroenterol Hepatol; 2019 Oct; 34(10):1696-1702. PubMed ID: 30811663
[TBL] [Abstract][Full Text] [Related]
15. Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report.
Malfertheiner P; Mégraud F; O'Morain C; Hungin AP; Jones R; Axon A; Graham DY; Tytgat G;
Aliment Pharmacol Ther; 2002 Feb; 16(2):167-80. PubMed ID: 11860399
[TBL] [Abstract][Full Text] [Related]
16. [A multicenter randomized controlled study of bismuth-containing quadruple therapy followed by Jing-Hua-Wei-Kang in the treatment of patients newly diagnosed with
Ma PP; Meng LN; Wang MT; Jin HF; Fan YH; Zha AS; Huo XH; Chen DF; Cao ZQ; Tang XF; Yang P; Shi ZH; Li TW; Meng J; Gan C; Chen GX; Sha WH; Du Q; Li Y; Lyu B
Zhonghua Yi Xue Za Zhi; 2021 Jul; 101(26):2060-2065. PubMed ID: 34275239
[No Abstract] [Full Text] [Related]
17. Helicobacter pylori infection: approach of primary care physicians in a developing country.
Ahmed S; Salih M; Jafri W; Ali Shah H; Hamid S
BMC Gastroenterol; 2009 Apr; 9():23. PubMed ID: 19358721
[TBL] [Abstract][Full Text] [Related]
18. Ten-Day Quadruple Therapy Comprising Proton Pump Inhibitor, Bismuth, Tetracycline, and Levofloxacin is More Effective than Standard Levofloxacin Triple Therapy in the Second-Line Treatment of Helicobacter pylori Infection: A Randomized Controlled Trial.
Hsu PI; Tsai FW; Kao SS; Hsu WH; Cheng JS; Peng NJ; Tsai KW; Hu HM; Wang YK; Chuah SK; Chen A; Wu DC
Am J Gastroenterol; 2017 Sep; 112(9):1374-1381. PubMed ID: 28719592
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of bismuth-based quadruple therapy for eradication of Helicobacter pylori infection based on previous antibiotic exposure: A large-scale prospective, single-center clinical trial in China.
Zhou JJ; Shi X; Zheng SP; Tang D; Cai T; Yao Y; Wang F
Helicobacter; 2020 Dec; 25(6):e12755. PubMed ID: 32914914
[TBL] [Abstract][Full Text] [Related]
20. [Helicobacter pylori - 2012].
Buzás GM
Orv Hetil; 2012 Sep; 153(36):1407-18. PubMed ID: 22951408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
